Supplementary Data from Clinical Significance of &lt;i&gt;PIK3CA&lt;/i&gt; and &lt;i&gt;ESR1&lt;/i&gt; Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant